Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria

Clinical Infectious Diseases

Volumn 35, Issue 12, 2002, Pages 1469-1476

  Bouth Denis, Mey ^a,b   Davis, Timothy M E ^d   Hewitt, Sean ^a   Incardona, Sandra ^c   Nimol, Khim ^c   Fandeur, Thierry ^c   Poravuth, Yi ^b   Lim, Chiv ^b   Socheat, Doung ^b  

^a European Commission   (Cambodia)

^b National Malaria Center   (Cambodia)

^c INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEKIN; DIHYDROARTEMISININ; PIPERAQUINE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ANOREXIA; ARTICLE; BLOOD SMEAR; CAMBODIA; CHILD; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; NAUSEA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PRURITUS; RECURRENT DISEASE; VERTIGO; VOMITING;

ADOLESCENT; ADULT; ANTIMALARIALS; ARTEMISININS; CAMBODIA; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; QUINOLINES; SESQUITERPENES; TREATMENT OUTCOME;

EID: 0037115230     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/344647     Document Type: Article

References (33)

1. Hien TT, White NJ. Qinghaosu. Lancet 1993; 341:603-8.
2. Barradell LB, Fitton A. Artesunate: A review of its pharmacology and therapeutic efficacy in the treatment of malaria. Drugs 1995; 50:714-41.
3. Warhurst DC. Drug resistance in Plasmodium falciparum malaria. Infection 1999;27(Suppl 2):S55-8.
4. World Health Organization (WHO). Antimalarial Drug Combination Therapy: Report of a WHO Technical Consultation. WHO/CDS/RBM/2001.35. Geneva: WHO, 2001.
5. Nosten F, van Vugt M, Price R, et al. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: A prospective study. Lancet 2000; 356:297-302.
6. Phillips-Howard P, ter Kuile F. CNS adverse events associated with antimalarial agents: Fact or fiction? Drug Saf 1995; 12:370-83.
7. Chen L, Dai ZR, Qian YL, et al. Observation on the efficacy of combined use of some new antimalarials for the treatment of falciparum malaria in Hainan Province [in Chinese]. Chin J Parasitol Parasitic Dis 1989; 7:81-4.
8. Chen L, Qu F-Y, Zhou Y-C. Field observations of the antimalarial piperaquine. Chin Med J 1982;95:281-6.
9. Development Health Vietnam. Medicine for the National Malaria Control Project. Intellasia [serial online] 25 April 2001:8. Available at: http://www.intellasia.com.
10. Looareesuwan S, Wilairatana P, Vanijanonta S, Pitisuttithum P, Viravan C, Kraisintu K. Treatment of acute, uncomplicated, falciparum malaria with oral dihydroartemisinin. Ann Trop Med Parasitol 1996; 90:21-8.
11. World Health Organization (WHO). Chemotherapy of malaria and resistance to anti-malarials: Report of a WHO scientific working group. WHO Technical Report Series 529. Geneva: WHO, 1973.
12. World Health Organization (WHO). Assessment of Therapeutic Efficacy for Uncomplicated Falciparum Malaria in Areas of Intense Transmission. WHO/MAL/96:1077. Geneva: WHO, 1996.
13. Huong NM, Hewitt S, Davis TME, et al. Resistance of Plasmodium falciparum to antimalarial drugs in a highly endemic area of southern Vietnam: A study in vivo and in vitro. Trans R Soc Trop Med Hyg 2001; 95:325-9.
14. Contamin H, Fandeur T, Bonnefoy S, Skouri F, Ntoumi F, Mercereau-Puijalon O. PCR typing of field isolates of Plasmodium falciparum. J Clin Microbiol 1995; 33:944-51.
15. Robert F, Ntoumi F, Angel G, et al. Extensive genetic diversity of Plasmodium falciparum isolates collected from patients with severe malaria in Dakar, Senegal. Trans R Soc Trop Med Hyg 1996; 90:704-11.
16. Carcy B, Bonnefoy S, Guillotte M, et al. A large multigene family expressed during the erythrocytic schizogeny of Plasmodium falciparum. Mol Biochem Parasitol 1994; 68:221-33.
17. Prescott N, Stowers AW, Cheng Q, Bobogare A, Rzepczyk CM, Saul A. Plasmodium falciparum genetic diversity can be characterised using the polymorphic merozoite surface antigen 2 (MSA-2) gene as a single locus marker. Mol Biochem Parasitol 1994; 63:203-12.
18. Sakihama N, Mitamura T, Kaneko A, Horii T, Tanabe K. Long PCR amplification of Plasmodium falciparum DNA extracted from filter paper blots. Exp Parasitol 2001;97:50-4.
19. Brewer TG, Grate SJ, Peggins JO, et al. Fatal neurotoxicity of arteether and artemether. Am J Trop Med Hyg 1994;51:251-9.
20. Ribeiro IR, Olliaro P. Safety of artemisinin and its derivatives: A review of published and unpublished clinical trials. Med Trop (Mars) 1998; 58(Suppl 3):50-3.
21. Chen L, Dai ZR, Ma ZM, Zheng XY, Chen C. Studies on residual antimalarial activity of tripynadine in mice and monkeys [in Chinese]. Chin J Parasitol Parasitic Dis 1993; 11:190-4.
22. Lan CX, Lin X, Huang ZS, Chen YS, Guo RN. In vivo sensitivity of Plasmodium falciparum to piperaquine phosphate assayed in Linshui and Baisha Counties, Hainan Province [in Chinese]. Chin J Parasitol Parasitic Dis 1989; 7:163-5.
23. Yang H, Liu D, Dong Y, et al. Sensitivity of Plasmodium falciparum to seven antimalarials in China-Laos border [in Chinese]. Chin J Parasitol Parasitic Dis 1995; 13:111-3.
24. Deloron P, Ramanamirija J, Le Bras J, et al. Sensibilite aux amino-4-quinolines de Plasmodium falciparum a Madagascar. Arch Inst Pasteur Madagascar 1984; 51:29-42.
25. Zhang KY, Zhou JX, Wu Z, Huang QL. Susceptibility of Plasmodium falciparum to chloroquine, piperaquine, amodiaquine, mefloquine and quinine with in vitro microtechnique in Hainan Island [in Chinese]. Chin J Parasitol Parasitic Dis 1987; 5:165-9.
26. Phillips RE, Looareesuwan S, Warrell DA, et al. The importance of anaemia in cerebral and uncomplicated falciparum malaria: Role of complications, dyserythropoiesis and iron sequestration. Q J Med 1986; 58:305-23.
27. Tran Quang Binh, Ilett KF, Batty KT, et al. Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malaria. Br J Clin Pharmacol 2001; 51:541-6.
28. Krishna S, White NJ. Pharmacokinetics of quinine, chloroquine and amodiaquine: Clinical implications. Clin Pharmacokinet 1996; 30:263-99.
29. Vennerstrom J, Ellis W, Ager A, et al. Bisquinolines: 1-N,N-bis(7-chlorquinolin-4-yl)alkanediamines with potential against chloroquine-resistant malaria. J Med Chem 1992; 35:2129-34.
30. Guan WB, Huang WJ, Zhou YC, et al. Effect of piperaquine and hydroxypiperaquine on a chloroquine-resistant strain of Plasmodium falciparum. Chin J Parasitol Parasit Dis 1983; 1:88-90.
31. Looareesuwan S, White NJ, Chittamas S, Bunnag D, Harinasuta T. High rate of Plasmodium vivax following treatment of falciparum malaria in Thailand. Lancet 1987; 2:1052-5.
32. Chen PQ, Li GQ, Guo XB, et al. The infectivity of gametocytes of Plasmodium falciparum from patients treated with artemisinin. Chin Med J 1994; 107:709-11.
33. Price RN, Nosten F, Luxemburger C, et al. Effects of artemisinin derivatives on malaria transmissibility. Lancet 1996; 347:1654-8.